Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-Free Anaesthesia in Bladder Diversion Surgery
NCT05262166Unknown
- Sponsor
- Mansoura University
- Start
- Mar 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in bladder cancer (2 arms), sponsored by Mansoura University. Primary endpoint: Total postoperative analgesic fentanyl dose at 24 hours. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT05262166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05262166.